Learn, Analyse & Invest
only with
only with
+91
Download Orca
Vivanza Biosciences Ltd.
Vivanza Biosciences
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹9.64 Cr.
| EX-Date | Purpose |
|---|---|
| 28 06 2021 | Audited Results |
| 24 07 2021 | Quarterly Results |
| 28 10 2021 | Quarterly Results |
| 10 02 2022 | Quarterly Results |
| 27 05 2022 | Quarterly Results & Preferential Issue of shares & Audited Results & A.G.M. |
| 15 06 2022 | A.G.M. |
| 21 06 2022 | Preferential Issue of shares Inter alia, to transact the following business: 1) To Consider and Approve the Valuation Report by the Registered Independent Valuer for the purpose of Preferential Allotment; 2) To Approve the Relevant Date for the purpose of Preferential Allotment. 3) Any other business as Board deem fit to discuss, with the permission of the Chair. |
| 21 07 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 24 01 2023 | Stock Split & Quarterly Results & Inter alia, to consider and approve :- 1. Un-audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter and Nine Months ended on December 31st, 2022; 2. Proposal for sub-division of the Equity shares of the Company having a face value of Rs. 10/- each in such manner as may be determined by the Board of Directors; 3. Alteration of Authorised Share Capital clause of the Company; 4. Approved the draft notice of Extra-Ordinary General Meeting (EOGM); 5. Fix the Book Closure date for the purpose of Extra-Ordinary General Meeting (EOGM); 6. Appoint scrutinizer to ascertain voting process of Extra-Ordinary General Meeting (EOGM); 7. Any other business with the permission of chair; |
| 04 03 2023 | Stock Split & Inter alia, to consider and approve the ?Record Date? for the purpose of determining eligibility of shareholders for the purpose of sub-division of one (1) Equity Share having face value of Rs.10/- (Rupees Ten) each into 10 (Ten) Equity Shares of nominal value of Rs. 1/- each in the Share Capital of the Company as approved by the Shareholder in the Extra-Ordinary General Meeting of the Company held on Friday, February 24, 2023 and any other business with the permission of Chair. |
| 29 03 2023 | Independent Director Meeting |
| 25 04 2023 | Audited Results Inter alia, to consider and approve :- 1. Audited standalone and consolidated financial statements and financial results of the Company for the quarter and year ended March 31, 2023; 2. Appointment of Independent Director on the Board of the Company; 3. Appointment of Managing Director of the Company; |
| 30 06 2023 | A.G.M. & Inter alia, to consider and approve :- 1) To consider and approve the Director?s Report and Secretarial Audit Report along with annexure for the Financial Year 2022-23. 2) Appointment of Chintan K. Patel, Company Secretary as a Secretarial Auditor of the Company for the financial year 2023-24. 3) To propose regularization of appointment of Ms. Apeksha Vyas (DIN: 09469295) as Non-Executive Independent Director of the Company in the ensuing Annual General Meeting. 4) To approve the draft notice of 41st Annual General Meeting (AGM). 5) To consider and fix the Book Closure date for the purpose of 41st Annual General Meeting (AGM). 6) To appoint scrutinizer to ascertain voting process of 41st Annual General Meeting (AGM). 7) Increase in borrowing limits to Rs. 20,00,00,000/- (Rupees Twenty Crore) or the aggregate of the paid up capital and free reserves of the Company, whichever is higher. 8) Any other business as Board deem fit to discuss, with the permission of the Chair |
| 10 08 2023 | Quarterly Results |
| 26 10 2023 | Quarterly Results |
| 06 02 2024 | Quarterly Results |
| 17 10 2024 | Quarterly Results |
| 12 05 2025 | Quarterly Results & Audited Results |
News
No News data available
